Biogen
(NASDAQ:BIIB)
202.90
00
At close: May 17
202.90
00
PreMarket: 4:55PM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low187.16 - 468.55
Open / Close- / -
Float / Outstanding129.8M / 146.5M
Vol / Avg.- / 1.1M
Mkt Cap29.7B
P/E20.77
50d Avg. Price206.74
Div / Yield-
Payout Ratio-
EPS2.06
Total Float129.8M

Biogen (NASDAQ:BIIB), Quotes and News Summary

Biogen (NASDAQ: BIIB)

Day High/Low- - -
52 Week High/Low187.16 - 468.55
Open / Close- / -
Float / Outstanding129.8M / 146.5M
Vol / Avg.- / 1.1M
Mkt Cap29.7B
P/E20.77
50d Avg. Price206.74
Div / Yield-
Payout Ratio-
EPS2.06
Total Float129.8M
load more
Sector: Health Care.Industry: Biotechnology
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-21
REV
Q1 2022Est.ActualSurprise
EPS4.3803.620 -0.7600
REV2.490B2.532B42.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Biogen Questions & Answers

Q
How do I buy Biogen (BIIB) stock?
A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q
What is the target price for Biogen (BIIB) stock?
A

The latest price target for Biogen (NASDAQ: BIIB) was reported by Morgan Stanley on Wednesday, May 4, 2022. The analyst firm set a price target for 285.00 expecting BIIB to rise to within 12 months (a possible 40.46% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Biogen (BIIB)?
A

The stock price for Biogen (NASDAQ: BIIB) is $202.9 last updated May 17, 2022, 8:00 PM UTC.

Q
Does Biogen (BIIB) pay a dividend?
A

There are no upcoming dividends for Biogen.

Q
When is Biogen (NASDAQ:BIIB) reporting earnings?
A

Biogen’s Q2 earnings are confirmed for Thursday, July 21, 2022.

Q
Is Biogen (BIIB) going to split?
A

There is no upcoming split for Biogen.

Q
What sector and industry does Biogen (BIIB) operate in?
A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.